Talk:Assessment of the health impacts of H1N1 vaccination

Pandemrix should not be used because of narcolepsy risk

How to read discussions

Fact discussion: .
Opening statement: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. Closing statement: Resolution not yet found. (A closing statement, when resolved, should be updated to the main page.)
Argumentation: ⇤--1: . Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST) (type: truth; paradigms: science: attack) ←--2: . The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST) (type: truth; paradigms: science: defence) ←--3: . In Finland, THL decided to stop the use of Pandemrix. --Jouni 23:05, 31 March 2011 (EEST), [1] (type: truth; paradigms: science: defence)

Discussion groups:

• Talk:Assessment of the health impacts of H1N1 vaccination/Group A
• Talk:Assessment of the health impacts of H1N1 vaccination/Group B
• Talk:Assessment of the health impacts of H1N1 vaccination/Group C
• Talk:Assessment of the health impacts of H1N1 vaccination/Group D
• Talk:Assessment of the health impacts of H1N1 vaccination/Group E

Additional material:

• File:Swine flu story.ppt
• Decision analysis and risk management#See also